Johnson & Johnson (JNJ) Stock: A Closer Look at the Market Potential
The price-to-earnings ratio for Johnson & Johnson (NYSE: JNJ) is above average at 26.45x, Company’s 36-month beta value is 0.53.Analysts have differing opinions on the
The price-to-earnings ratio for Johnson & Johnson (NYSE: JNJ) is above average at 26.45x, Company’s 36-month beta value is 0.53.Analysts have differing opinions on the
The stock of Johnson & Johnson (NYSE: JNJ) has decreased by -0.07 when compared to last closing price of 152.50.Despite this, the company has seen
Johnson & Johnson (NYSE: JNJ) has a price-to-earnings ratio of 28.36x that is above its average ratio. Additionally, the 36-month beta value for JNJ is
Johnson & Johnson (NYSE: JNJ)’s stock price has gone decline by -0.01 in comparison to its previous close of 155.23, however, the company has experienced
Johnson & Johnson (NYSE: JNJ) has a price-to-earnings ratio of 27.83x that is above its average ratio. Additionally, the 36-month beta value for JNJ is
In the past week, JNJ stock has gone down by -0.84%, with a monthly gain of 1.57% and a quarterly surge of 1.53%. The volatility
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.